Clinical trial
Single Dose Population Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients
NCT02968134 is registered in ClinicalTrials.gov with Royal Brisbane and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single Dose Population Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients
- Lead sponsor
- Royal Brisbane and Women's Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 16, 2017
- Completion date
- May 21, 2017
- Enrollment
- 8 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
systemic fungal infections